Swiss National Bank’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $704K | Sell |
62,000
-5,300
| -8% | -$60.2K | ﹤0.01% | 2254 |
|
|
2025
Q1 | $448K | Hold |
67,300
| – | – | ﹤0.01% | 2356 |
|
|
2024
Q4 | $742K | Buy |
67,300
+11,400
| +20% | +$126K | ﹤0.01% | 2324 |
|
|
2024
Q3 | $687K | Sell |
55,900
-10,500
| -16% | -$129K | ﹤0.01% | 2356 |
|
|
2024
Q2 | $897K | Buy |
+66,400
| New | +$897K | ﹤0.01% | 2216 |
|
|
2023
Q4 | – | Sell |
-43,300
| Closed | -$171K | – | 2603 |
|
|
2023
Q3 | $171K | Hold |
43,300
| – | – | ﹤0.01% | 2605 |
|
|
2023
Q2 | $460K | Buy |
43,300
+9,200
| +27% | +$97.8K | ﹤0.01% | 2549 |
|
|
2023
Q1 | $284K | Sell |
34,100
-3,100
| -8% | -$25.8K | ﹤0.01% | 2615 |
|
|
2022
Q4 | $343K | Hold |
37,200
| – | – | ﹤0.01% | 2637 |
|
|
2022
Q3 | $478K | Buy |
37,200
+2,400
| +7% | +$30.8K | ﹤0.01% | 2585 |
|
|
2022
Q2 | $460K | Buy |
34,800
+4,300
| +14% | +$56.8K | ﹤0.01% | 2631 |
|
|
2022
Q1 | $642K | Buy |
30,500
+2,300
| +8% | +$48.4K | ﹤0.01% | 2543 |
|
|
2021
Q4 | $677K | Hold |
28,200
| – | – | ﹤0.01% | 2593 |
|
|
2021
Q3 | $717K | Hold |
28,200
| – | – | ﹤0.01% | 2518 |
|
|
2021
Q2 | $949K | Buy |
28,200
+7,600
| +37% | +$256K | ﹤0.01% | 2500 |
|
|
2021
Q1 | $800K | Buy |
20,600
+1,800
| +10% | +$69.9K | ﹤0.01% | 2395 |
|
|
2020
Q4 | $1.16M | Sell |
18,800
-3,100
| -14% | -$192K | ﹤0.01% | 2220 |
|
|
2020
Q3 | $733K | Hold |
21,900
| – | – | ﹤0.01% | 2247 |
|
|
2020
Q2 | $522K | Buy |
21,900
+6,300
| +40% | +$150K | ﹤0.01% | 2373 |
|
|
2020
Q1 | $357K | Hold |
15,600
| – | – | ﹤0.01% | 2302 |
|
|
2019
Q4 | $442K | Buy |
+15,600
| New | +$442K | ﹤0.01% | 2447 |
|